FOSAMPRENAVIR

Search structure
Synonyms:
Status: Approved (2003)
Entry Type: Small molecule
Molecule Category: Parent Prodrug
ATC: J05AE07
UNII: WOU1621EEG

Structure
InChI Key MLBVMOWEQCZNCC-OEMFJLHTSA-N
Smile CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1
InChI
InChI=1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H36N3O9PS
Molecular Weight 585.62
AlogP 2.52
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 13.0
Polar Surface Area 177.72
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 39.0

Indications

Mesh Heading Maximum Phase Mesh ID Reference
HIV Infections 3 D015658 ClinicalTrials
HIV Infections 3 D015658 ClinicalTrials
Acquired Immunodeficiency Syndrome 3 D000163 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 226700-79-4
ChEBI 82941
ChEMBL CHEMBL1664
DrugBank DB01319
DrugCentral 1240
EPA CompTox DTXSID2048296
FDA SRS WOU1621EEG
Human Metabolome Database HMDB0015416
PharmGKB PA10084
PubChem 131536
SureChEMBL SCHEMBL34080
ZINC ZINC000003941829
CONTENTS